Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accutar, Adjutor Healthcare, Ainos, Ascletis, Astrazeneca, Beigene, Biontech, Innocare, Keymed, Merck, Novavax, Pfizer, Takeda, Valneva, Veru.